NCT01750437View on ClinicalTrials.gov

Phase 2 Clinical Trial to Investigate the Safety, Tolerability and Efficacy of YH1885L in Patients With Non-erosive Reflux Disease(NERD)

PHASE2CompletedINTERVENTIONAL
Enrollment

149

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

October 31, 2013

Study Completion Date

April 30, 2014

Conditions
Non-erosive Reflux Disease
Interventions
DRUG

YH1885L(Revaprazan)

DRUG

Esomeprazole 20mg

DRUG

placebo

Trial Locations (10)

Unknown

Catholic yeouido sungmo hospital, Seoul

DongA university hospital, Busan

Kyungbook University hospital, Daegu

Chungnam university hospital, Daejeon

Catholic Incheon hospital, Incheon

Jeonbuk University hospital, Jeonju

Asan hospital, Seoul

Konkuk unversity hospital, Seoul

Kyunghee university hospital, Seoul

Seoul university hospital, Seoul

All Listed Sponsors
lead

Yuhan Corporation

INDUSTRY

NCT01750437 - Phase 2 Clinical Trial to Investigate the Safety, Tolerability and Efficacy of YH1885L in Patients With Non-erosive Reflux Disease(NERD) | Biotech Hunter | Biotech Hunter